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Huixin Xu 1,12, Ryann M. Fame 1,12, Cameron Sadegh 1,2, Jason Sutin3, Christopher Naranjo4, Della Syau4,
Jin Cui1, Frederick B. Shipley1,5, Amanda Vernon6,7,8, Fan Gao6,7,8,11, Yong Zhang9, Michael J. Holtzman9,
Myriam Heiman6,7,8, Benjamin C. Warf10, Pei-Yi Lin3 & Maria K. Lehtinen 1,5 ✉

Cerebrospinal ﬂuid (CSF) provides vital support for the brain. Abnormal CSF accumulation,
such as hydrocephalus, can negatively affect perinatal neurodevelopment. The mechanisms
regulating CSF clearance during the postnatal critical period are unclear. Here, we show that
CSF K+, accompanied by water, is cleared through the choroid plexus (ChP) during mouse
early postnatal development. We report that, at this developmental stage, the ChP showed
increased ATP production and increased expression of ATP-dependent K+ transporters,
particularly the Na+, K+, Cl−, and water cotransporter NKCC1. Overexpression of NKCC1 in
the ChP resulted in increased CSF K+ clearance, increased cerebral compliance, and reduced
circulating CSF in the brain without changes in intracranial pressure in mice. Moreover, ChPspeciﬁc NKCC1 overexpression in an obstructive hydrocephalus mouse model resulted in
reduced ventriculomegaly. Collectively, our results implicate NKCC1 in regulating CSF K+
clearance through the ChP in the critical period during postnatal neurodevelopment in mice.
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balance between cerebrospinal ﬂuid (CSF) production
and clearance (inﬂux/efﬂux) is essential for normal brain
function and development1. Disrupted CSF volume
homeostasis with excessive CSF accumulation is implicated in
pediatric brain disorders, in particular congenital hydrocephalus2,
where patients suffer from a potentially life-threatening accumulation of CSF and frequently develop neurological deﬁcits that
last through childhood and into adult life3. Often schizophrenia
patients have enlarged lateral ventricles by their ﬁrst episode of
psychosis4, in some cases as early as infancy5, suggesting a role for
CSF clearance abnormalities in this and possibly other neurodevelopmental disorders. As another example, autism spectrum
disorders are associated with altered CSF distribution patterns
and enlarged CSF space surrounding the brain6. A better
understanding of developing CSF dynamics may help explain
why early phases of brain development (e.g., from third trimester
to 6 months after birth in human) represent a period of high
vulnerability to certain congenital disorders5–7.
Critically, how CSF is cleared during this perinatal period
remains a mystery. Progress in CSF dynamics research has
identiﬁed several putative CSF clearance routes including arachnoid villi and granulations in human (and only arachnoid villi
in non-human mammalian species), perineural and paravascular
pathways, and meningeal lymphatics1,8,9. While many mechanistic questions and validation work remain regarding the identiﬁed routes8–10, their developmental time-courses are even less
understood. In human, arachnoid granulations are not fully
formed until 2 years of age. In other mammalian species (rats,
pigs, and sheep), lymphatic vessels contribute to CSF clearance by
connecting with CSF spaces around the cribriform plate and
olfactory nerve roots during perinatal brain development11–13.
Similarly, lymphatic structures begin to sprout at the base of the
skull around birth in mice, but mature throughout the ﬁrst
postnatal month14. Thus, available data suggest that the abovementioned CSF clearance routes are unlikely to fully account for
CSF outﬂow during the critical and sensitive early phase of brain
development. Identifying and manipulating the early endogenous
CSF clearance mechanisms could provide one powerful approach
for tackling neurodevelopmental disorders involving CSF dysregulation, and may also be applied to ﬂuid disorders affecting
adults.
To identify how early CSF is cleared, we investigated tissues
with the ability to modulate CSF at this stage. The choroid plexus
(ChP) is an intraventricular epithelial structure that forms the
majority of the blood-CSF barrier and emerges prenatally. It
contains diverse ion and ﬂuid transporters along its vast surface
area15. Although the prevailing model posits that the ChP provides net luminal secretion of ions and water to form CSF in adult
brains16–18, historical clinical observations suggest some absorptive functions of the ChP19, which is supported by animal studies20. Moreover, extensive studies have documented ion
gradients driving bidirectional trafﬁcking at the ChP-CSF interface through various ChP transporters15,21,22. Furthermore, broad
transcriptional changes of the machinery regulating ﬂuid/ion
transport support the concept of temporally dynamic and possibly context-dependent ChP functions in determining net
directionality of CSF transport23,24.
To further explore potentially absorptive properties of the early
ChP, we studied the expression of transporters, the energy systems and ionic gradients that govern their activity, and their
physiological effects across the timespan of early postnatal
development in mice. Taken together our data support a previously undescribed developmental mechanism for net CSF
clearance by the Na+-K+-Cl− and water cotransporter, NKCC1,
on the apical membrane of the ChP during a speciﬁc stage. While
NKCC1 retains bidirectional transporter potential throughout
2

life, its role in mediating net CSF-to-ChP transport during the
early postnatal period of brain development critically inﬂuenced
the establishment of CSF ion and ﬂuid homeostasis. These results
have implications for the pathophysiology of congenital disorders
accompanied by dysregulated CSF and could inform strategies for
treatment of neonatal hydrocephalus and perhaps other
disorders.
Results
CSF K+ declines precipitously during a speciﬁc perinatal period. We discovered a unique and transient phase of neurodevelopment when CSF [K+] decreased rapidly. We used inductively
coupled plasma–optical emission spectrometry (ICP-OES) and
ion chromatography (IC) to measure levels of key ions likely to
govern CSF ﬂux including Na+, K+, and Cl− at several developmental timepoints. CSF [K+] was remarkably high at birth (9.6
± 3.5 mM), decreased rapidly to 4.4 ± 0.9 mM by P7 (Fig. 1a), and
later achieved adult levels of 3.1 ± 0.6 mM (Fig. 1a) while [Na+]
was minimally changed and [Cl−] slightly increased (Supplementary Table 1 shows developmental CSF [K+], [Na+], [Ca2+],
[Mg2+], [Cl−]). Notably, the CSF-to-serum [K+] ratio decreased
sharply from P0 to P7 (Fig. 1b), suggesting that the onset of CSF
clearance occurs during this window25. Similar trends of CSF
[K+] decrease as development proceeds have been reported in
many other species perinatally, although by far none have shown
a decrease as drastic as in mice, perhaps reﬂecting different stages
of brain development at the times of sampling17,26. Studies in
adult animals have shown rapid clearance of K+ out of the CSF
when the concentrations are higher than homeostatic levels27–29,
supporting the concept that CSF [K+]-sensitive mechanisms exist
and can mediate K+ clearance in a timely manner. Notably, K+
transport has been associated with water co-transport by several
K+ transporters in various tissues and cell types30–32, suggesting
that CSF [K+] changes could drive water movement in the brain
as well. Therefore, we sought to identify mechanisms underlying
this fast clearance of CSF K+, which may shed light on CSF
outﬂow during this time.
ChP metabolic rate increases during the early postnatal transition phase. The transitional period of rapid CSF K+ clearance
coincided with high ChP metabolism (Fig. 1a, b, h, i). We reasoned that K+ clearance during this period could be ChPmediated because the ChP expresses high levels of K+ cotransporters on its large CSF-contacting surface area15,33. Similar
to water and ion transport by other epithelial structures such as
kidney proximal and distal tubes34, K+ clearance from CSF by the
ChP would be energy-dependent and therefore be accompanied
by upregulation of ATP production and mitochondrial activity.
Therefore, we evaluated the metabolic status and ATP production
capacity of the ChP epithelium before, during, and after the time
period of CSF [K+] reduction. We found that both mitochondria
number and size increased from E16.5 to 2 months old (2mo,
referred to as “adult”) (Fig. 1c–f), while cellular glycogen load
gradually decreased (Supplementary Fig. 1). Both observations
are consistent with reports from ChP in other mammalian
species33,35 and suggest functional changes in ChP oxidative
metabolism. We used Agilent Seahorse XFe technology to
monitor oxygen consumption as an index of the metabolic status
of the ChP in explants from embryonic day 16.5 (E16.5), postnatal day 0 (P0), P7, and adult mice. We then calculated basal
metabolism and ATP production (Fig. 1g–i, Supplementary
Fig. 2). E16.5 ChP had the lowest basal respiration of all tested
ages (Fig. 1h, Supplementary Fig. 2). Adult had a higher capacity
for overall ATP production than E16.5 ChP, but surprisingly,
P0–P7 ChP were the most metabolically active as per ATP
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Fig. 1 Postnatal CSF [K+] decrease coincides with increased choroid plexus metabolism. a ICP-OES quantiﬁcation of CSF [K+]. Colors: blue-to-red
indicate increasing age in all panels. ***p = 0.0009, ****p < 0.0001; Sidak’s test. b Developmental CSF/Serum [K+] ratios. Ratio = CSF [K+]/average
serum [K+]; Sidak’s test. *p = 0.0202. c Transmission micrographs of LVChP mitochondria. d–f Quantiﬁcation of mitochondrial number (d), area (e), and
% area occupancy (f) in ChP epithelial cells. d *p = 0.0269; e E16.5 vs. P7 **p = 0.0025; E16.5 vs. adult *p = 0.0115; P0 vs. P7 **p = 0.0062; P0 vs. adult
*p = 0.0344; f E16.5 vs. P7 *p = 0.0112; E16.5 vs. adult ***p = 0.0008; P0 vs. P7 **p = 0.0010; P0 vs. adult ****p < 0.001; P7 vs. adult **p = 0.0010;
Welch’s two-tailed unpaired t-test. g Schematic of explant-based Agilent Seahorse XFe96 test. h, i Oxidative respiration metrics over development; OCR
oxygen consumption rate. h E16.5 vs. P0 ****p < 0.0001; E16.5 vs. P7 ***p = 0.0025; E16.5 vs. Adult ****p < 0.0001; i E16.5 vs. P0 ****p < 0.0001; E16.5 vs.
P7 **p = 0.0022; E16.5 vs. Adult **p = 0.0037; P0 vs. Adult **p = 0.0012; P7 vs. Adult *p = 0.0480; Welch’s ANOVA with Dunnett’s T3 multiple
comparison test. j, k Mitochondrial distribution apical: basal proximity ratio: 1 = apical surface. 0 = basal surface. Solid line: median; dashed line: upper/
lower quartiles. ****p < 0.0001; Kolmogorov–Smirnov test. l Cumulative distribution of mitochondrial localization. Solid lines: mean; shaded area: range.
Scale bar = c 250 nm, j 2 μm. All quantitative data presented as mean ± SEM. LVChP lateral ventricle choroid plexus, E embryonic day, P postnatal day.
Information on replicates and reproducibility for this ﬁgure can be found in the “Statistics and Reproducibility” section of the Methods. Source data are
provided as a Source Data ﬁle.
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production (Fig. 1h, i). In addition, mitochondrial subcellular
distribution in ChP epithelium was biased toward the apical
surface as postnatal development proceeded, with E16.5 mitochondria heavily distributed along the basal side of epithelial cells,
P0 mitochondria intermediately localized, and P7 and adult
mitochondria having more apical distribution (Fig. 1j–l, Supplementary Fig. 3). Mitochondrial subcellular localization responds
to regional energy demand in other cellular processes, such as
migration of mouse embryonic ﬁbroblasts and during axonal
outgrowth36,37. Together with the increase in ATP production
postnatally, the shift in ChP epithelial cell mitochondrial distribution over postnatal development suggests increasing ATP
supply to meet high demand at the apical ChP surface during the
early postnatal phase, concurrent with the rapid clearance of CSF
K+. Although many processes at the ChP apical surface consume
ATP and could drive the mitochondrial distribution shift during
this phase, this concurrence prompted us to investigate
mechanisms whereby ChP epithelial cells might contribute to K+
clearance through ATP-dependent mechanisms.
The ChP increases production of CSF-facing ion and water
transporters postnatally. Consistent with rapid CSF K+ clearance and high ChP metabolism, we found that expression of
energy-dependent cation transport pathway components was
upregulated in ChP postnatally. To identify which of the ChP
transporters are likely candidates controlling postnatal CSF
clearance through the ChP, we conducted ribosomal proﬁling to
investigate transcripts that are prioritized for translation in
embryonic (E16.5) and adult ChP, using Translating Ribosomal
Afﬁnity Puriﬁcation (TRAP38). ChP epithelial cells were targeted
by crossing FoxJ1:cre mice39 with TRAP (EGFP:L10a) mice38
(Fig. 2a, Supplementary Fig. 4a, b), and mRNA associated with
the L10a ribosomal subunit were puriﬁed for sequencing.
TRAP analyses revealed 1967 differentially translated transcripts (adjusted p < 0.05) between E16.5 and adult ChP: 1119
enriched at E16.5 and 847 enriched in adults (Fig. 2b). Gene set
and pathway analyses revealed developmentally regulated ChP
programs. Adult ChP had enriched functional gene sets
associated with active transmembrane membrane transport and
mitochondria, which is consistent with our abovementioned
ﬁndings on metabolism changes (Fig. 2c). Notably, cation
transport was enriched, supporting the hypothesis of ChP
mediating CSF K+ transport postnatally (Fig. 2c, d, and
Supplementary Data 1). Enriched pathways in the adult included
secretion associated pathways named for other, better-studied
secretory processes, including salivary and pancreatic secretion,
all of which have a special emphasis on water and ion
transmembrane transport (Supplementary Fig. 4c (red), d).
Consistent with a rise in ﬂuid and ion modulating machinery,
there was a striking enrichment of more transmembrane and
signal peptide-containing transcripts in adult ChP (Supplementary Fig. 4e, f, and Supplementary Data 2). In contrast, the water
channel AQP1, which is not directly responsive to any given ion
gradient, but rather depends on the overall osmolarity, remained
unchanged (Supplementary Fig. 4h). These results indicate that
the ChP gained ﬂuid and ion modulatory functions postnatally,
with an emphasis on ion-related transporters and channels.
NKCC1 is poised to mediate perinatal ChP CSF K+ and water
clearance. Among all ﬂuid and ion modulating candidates with
increasing postnatal expression (Supplementary Fig. 4g, h), we
identiﬁed NKCC1 (Slc12a2) as the candidate most likely to
mediate CSF clearance. NKCC1 is functionally related to Na+/
K+-ATPase (Atp1a1 and Atp1b1), as the latter actively maintains
the Na+/K+ gradient that partially drives NKCC1 directionality.
4

Both the Na+/K+-ATPase and NKCC1 are capable of CSF K+
clearance, but NKCC1 was of particular interest because (1) it is a
cotransporter of K+ and water30,40; and (2) the activity of
NKCC1 can be further modiﬁed by phosphorylation41, lending
additional control over its ﬂuid/ion modulatory capacity. In
addition, NKCC1 is particularly enriched in the ChP and does not
impact broad functionality like the Na+/K+-ATPase does, both of
which are important features for a functional therapeutic intervention target. We reﬁned our temporal expression analyses of
NKCC1, ATP1a1, ATP1b1, and Klotho (Kl), which contributes to
the membrane localization of the Na+/K+-ATPase42,43 (Fig. 2e),
by sampling weekly from P0 to P28 and then from adult, and
conﬁrmed increased expression of transcript and protein for each
component across developmental time (Fig. 2f, g, Supplementary
Fig. 5). The observed changes in NKCC1 total protein were
corroborated by an independent approach where the rate of ChP
epithelial cell swelling under high [K+] challenge40 reﬂected the
abundance of NKCC1 protein (Fig. 2h–j, Supplementary Fig. 6).
Artiﬁcial CSF (aCSF) recipes that reﬂect the [K+] of neonatal vs.
adult CSF were used for respective ages (see Supplementary
Table 1 for recipes). Immunolabeling of NKCC1 showed its apical
membrane localization at all ages, regardless of abundance
(Supplementary Fig. 7).
In addition, we found particularly high levels of phosphorylated, therefore activated41, NKCC1 (pNKCC1) in the ChP of P0P7 pups, with P7 having peak pNKCC1 levels among all postnatal
ages, indicative of increased NKCC1 activity during the ﬁrst
postnatal week (Fig. 2g). Similar to the timeline of ChP ATP
production (Fig. 1i), the timeframe of high ChP pNKCC1 was
concurrent with the fast CSF [K+] decrease during the ﬁrst
postnatal week (Fig. 1a, b), suggesting a functional correlation
and further conﬁrming the signiﬁcance of the early postnatal
transitional period. Taken together, we identiﬁed ChP NKCC1 as
the top candidate for mediating postnatal CSF K+ and water
clearance.
NKCC1 temporal regulation requires epigenetic control that is
implicated in congenital hydrocephalus. We found that the
temporal proﬁle of NKCC1 expression was tightly regulated at the
epigenetic level by modulators implicated in some forms of
congenital hydrocephalus. The NuRD complex governs differentiation and maturation of diverse cells and tissues44. Our previously published RNA sequencing studies45 identiﬁed NuRD
components, including the ATPase CHD family members (Chd4
being the most highly expressed), the histone deacetylases
HDAC1/2, and methyl CpG-binding domain protein MBD3 in
the ChP (Fig. 3a). De novo loss-of-function CHD4 mutations are
implicated in some groups of children with congenital hydrocephalus and ventriculomegaly46. We found that CHD4 localized
to nuclei in mouse ChP epithelial cells beginning at P0 (Fig. 3b).
Immunoprecipitation of CHD4 identiﬁed HDAC1, HDAC2, and
MBD3 by immunoblotting in mouse ChP (Fig. 3c, technical
control for Co-IP protocol is shown in Supplementary Fig. 8),
conﬁrming the existence of the CHD4/NuRD complex in developing ChP. We then disrupted the complex by generating
ChP-Chd4 deﬁcient mice. Cre was expressed in Chd4 ﬂoxed mice
(Chd4 ﬂ/ﬂ)47 using an adeno-associated viral vector (AAV) with
tropism for the ChP (AAV2/5)48, delivered by in utero intracerebroventricular (ICV) injection at E14.5. Chd4 transcript levels
decreased to <50% by P7 (Fig. 3d). While CHD4 protein levels
only substantially decreased by P14 (Fig. 3e, g), we found that the
developmental increase of ChP NKCC1 expression was disrupted
as soon as the CHD4 protein decreased and lasted at least until
P28 (Fig. 3f, g). Similar results were also observed in 4VChP
(Fig. 3h, i). These data conﬁrm that the NuRD/ChD4 complex is
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one of the required components tightly regulating ChP NKCC1
developmental expression.
ChP NKCC1 actively mediates CSF clearance during the early
postnatal transition phase. To test whether NKCC1 is indeed
capable of transporting from CSF into the ChP during the period
of rapid CSF [K+] decline, we induced NKCC1 overexpression
(OE) in developing ChP epithelial cells using AAV2/5. NKCC1
transport directionality follows the combined Na+, K+, Cl−
gradients, which are close to neutral in adult brains and likely to
bias toward the CSF-to-ChP direction during the early postnatal
phase. NKCC1 protein level would be rate-limiting during the
early postnatal time when it is already highly phosphorylated,

5
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Time (min)

unlike in older mice where pNKCC1 only represented a small
portion of total NKCC1. The goal of this OE approach was to
accelerate endogenous ChP NKCC1 transport, thereby revealing
its directionality based on whether CSF [K+] clearance was
enhanced or delayed. AAV2/5-NKCC1, which expresses NKCC1
fused to an HA tag49, or control GFP virus was delivered by in
utero ICV at E14.5. Successful NKCC1 OE and increased
pNKCC1 was conﬁrmed in ChP at P0 (Fig. 4a–d). Appropriate
localization to apical membranes of epithelial cells, transduction
efﬁciency, and tissue speciﬁcity were also validated (Fig. 4e–i,
Supplementary Fig. 9a, b). Transcript levels of other K+ transporters or channels did not change following AAV2/5-NKCC1
transduction (Supplementary Fig. 9c). Because CSF [K+] sharply
decreased from P0 to P7 (Fig. 1a, b), we sampled CSF from ChP
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Fig. 2 Choroid plexus epithelial cells display age-dependent translation of ion and water transporters, in particular NKCC1. a Rpl10a-conjugated EGFP
expression in ChP epithelial cells after Foxj1-Cre recombination in TRAP-BAC mice. Scale bars = 500 μm. Representative of two experiments, each with two
biologically independent replicates. b Heatmap and hierarchical clustering of differentially expressed genes (adjusted p < 0.05). Red: enriched adult
expression. Blue: enriched E16.5 expression. c Top four gene functional clusters shown by DAVID to be enriched in Adult ChP epithelial cells over E16.5
ChP epithelial cells. d Top 10 signiﬁcantly enriched gene ontology (GO) terms for “Biological processes”. Plotted with horizontal lines for medians, bounds
of boxes for quartiles, and whiskers for maximum and minimum values. The log10 fold change (LogFC) is plotted for each expressed gene for the network.
Positive values (red): Adult enrichment; negative values (blue): E16.5 enrichment. Multiple measures were corrected using Bonferroni correction. **p ≤
0.01, ***p ≤ 0.001, ****p ≤ 0.0001 (See Supplementary Data S1 for exact p-values). e Schematics depicting the interaction of NKCC1, Na+/K+-ATPase, and
Klotho (Kl) on the apical membrane of a ChP epithelial cell. f, g RT-qPCR and immunoblotting of LVChP during postnatal development. f N = 4 biologically
independent animals from two experiments at each timepoint. Colors are matched to the gene’s protein name in Fig. 2e. g: representative of three
independent experiments, each with tissues from 1–2 animals (two animals for ages under P14, one animal for ages of P14 and older) pooled for each
timepoint. h Fluorescence images of Calcein-AM labeled epithelial cells from LVChP explants under high extracellular K+ challenge. Scale bar = 50 µm,
representative of four biological replicates collected from three independent experiments. Biological replicates with poor calcein labeling or visible damage
were excluded prior to K+ challenge. i, j Quantiﬁcation of ChP epithelia cellular volume by IMARIS 3D analysis. Percent volume increase = dV/V0 for each
timepoint (t). V0 = initial volume of the cell; t = subsequent timepoint after challenge; dV = Vt − V0 × 100%. At least ﬁve cells were analyzed for each
explant from each animal; N = 4 animals. Red: adults; light blue: P4. All quantitative data are presented as mean ± SD. Source data are provided as a Source
Data ﬁle.

NKCC1 OE and control mice at P1. We found that ChP NKCC1
OE reduced CSF [K+] more than controls, with their P1 CSF
[K+] values closely approximating those normally observed at P7
(Fig. 4j), indicating accelerated K+ clearance from CSF after
enhanced ChP NKCC1 activity. CSF total protein levels were
not affected (AAV2/5-GFP = 2.50 ± 0.20 mg/ml vs. AAV2/5NKCC1 = 2.71 ± 0.46 mg/ml; N = 6 from two litters each; p =
0.34, unpaired t-test). Overall, these ﬁndings support a model in
which, under physiological conditions with high early postnatal
CSF [K+], ChP NKCC1 transports K+ out of the CSF.
Next, we found that the circulating CSF volume in ChP
NKCC1 OE mice was reduced, as reﬂected by smaller lateral
ventricles. To avoid any tissue processing artifacts, we conducted
live T2-weighted magnetic resonance imaging (MRI) (Fig. 5a) to
quantify lateral ventricle volume. AAV-GFP mice were indistinguishable from naive wild-type mice at P14. In contrast,
NKCC1 OE mice had reduced lateral ventricle volumes (Fig. 5a,
b), without decrease in overall brain size (Fig. 5c), reﬂecting less
circulating CSF. The difference in ventricle sizes from these same
mice was sustained when measured again at P50 (AAV-GFP:
3.12 ± 0.59 mm3 vs. AAV-NKCC1: 1.28 ± 0.28 mm3, *p =
0.0182), suggesting ventricular deﬂation established early could
dictate long-term changes in ventricle structure.
The observed lack of ventricle enlargement at a later stage is
also consistent with the ﬁnding that only a small portion of
NKCC1 was phosphorylated in adult ChP (Fig. 2g), and therefore
overexpression without increased activation via phosphorylation
was unlikely to inﬂuence total NKCC1 transport in adulthood.
While the exact transport direction of NKCC1 in adult ChP is still
under debate24, the consistency in ventricular volume from P14
into later life supports our working model that because a
relatively small proportion of ChP NKCC1 was phosphorylated in
mice P14 and older (Fig. 2g), NKCC1 levels are not rate-limiting
and thus OE would not as substantially impact ChP functions in
older animals. Collectively, our ﬁndings demonstrate that ChP
NKCC1-mediated CSF clearance during the ﬁrst postnatal week.
Augmenting this process impacted CSF volume homeostasis in
the long term.
We then tested and found that enhancing CSF clearance
through ChP NKCC1 OE changed how the brain and cranial
space adapted to CSF volume changes. Intracranial compliance
(Ci) and CSF resistance (RCSF) describe the ability of the entire
intracranial space (including brain, meninges, and outﬂow routes)
to accommodate an increasing CSF volume that would otherwise
increase intracranial pressure (ICP). In humans, these parameters
are measured by a CSF constant rate infusion test50–52, and can
6

aid in diagnosis and evaluation of conditions like hydrocephalus,
which has decreased Ci2. ICP and RCSF have been previously
measured in rats53 using a similar test, quantifying ICP based on
mmH2O in a glass capillary. It was noted that RCSF changes with
infusion rate in a non-linear way, and RCSF was estimated based
on linear parts of the curve each representing high or low infusion
rates. We developed a miniaturized version of the human test
with a pressure sensor coupled with infusion tubing implanted
inside the lateral ventricles to determine the Ci and RCSF in mice.
The constant rate infusion test artiﬁcially increases CSF volume
by ICV infusion of aCSF, causing ICP to rise and plateau at a new
level (Fig. 5d, e). The Ci and RCSF are estimated from the ICP vs.
time curve using Marmarou’s model of CSF dynamics54
(Supplementary Fig. 10a). Simply put, the Ci is inversely
proportional to the rate of ICP increase, and the RCSF is related
to the level of the post-infusion ICP plateau (Fig. 5e). As a quality
control for the correct placement of infusion and measurement
catheter, arterial and respiratory pulsations were clearly visible in
the ICP waveform and their amplitude increased with volume
load as expected (Supplementary Fig. 10b, c). Using this
approach, we found that ChP NKCC1 OE signiﬁcantly increased
Ci at an age of 5–7 weeks (Fig. 5f, g), consistent with the brain
having greater capacity for CSF in ventricles “deﬂated” due to
excessive CSF clearance. Resting ICP and RCSF were unchanged
(Fig. 5h, i).
Enhanced ChP NKCC1 function mitigates ventriculomegaly in
a model of obstructive hydrocephalus. Our ﬁndings of enhanced
CSF clearance after ChP NKCC1 OE indicate that ChP NKCC1
can remove excess CSF. Therefore, we hypothesized that ChP
NKCC1 OE expression could mitigate ventriculomegaly in a
model of postnatal obstructive hydrocephalus. We ﬁrst overexpressed ChP NKCC1 at E14.5 by in utero AAV2/5 ICV, then
introduced obstructive hydrocephalus by a single unilateral
injection of kaolin into the lateral ventricle at P455, and ﬁnally
evaluated the lateral ventricle volumes by live T2 MRI at P14
(Fig. 6a). While both NKCC1 OE and control mice had enlarged
ventricles at P14, NKCC1 OE mice had reduced ventriculomegaly
compared to controls, with the average ventricle volume being
less than 1/3 of the controls (Fig. 6b–d; ventricles marked by blue
arrows; kaolin deposits marked by red arrows). Taken together,
our ﬁndings demonstrate that early, ChP targeted NKCC1 OE has
a sustained and broad impact on speciﬁc volumetric and biophysical parameters of the intracranial space with potential
therapeutic applications to hydrocephalus.
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Discussion
In this study, we sought to understand how CSF is cleared from
the brain during a period of development prior to the maturation
of CSF outﬂow routes suggested to exist in adults (e.g., arachnoid
granulations, arachnoid villi, perineural and paravascular pathways, and meningeal lymphatics)1,8,11–14,56. Failure of CSF
clearance during this developmental period has debilitating
consequences7. Our results suggest that this period is deﬁned by a
rapid decrease in CSF K+. The ChP mediates CSF K+ clearance
during this transition period, and thus forms a CSF outﬂow route
through ion and water co-transport by NKCC1 (Fig. 7). This CSF
clearance by the ChP during normal development contrasts
with the prevailing view that healthy ChP always mediates net
secretion (rather than absorption) of CSF. The prospect that the
ChP may in different contexts absorb or secrete CSF has been
previously hypothesized to occur under both physiological and
disease conditions15,19–22. Thus, our ﬁndings demonstrate
a precisely timed function of the developing ChP in CSF
8

clearance prior to the formation of other routes, and provide
targets for ﬂuid management intervention in hydrocephalus.
NKCC1 is a bidirectional transporter, recently shown to be an
important cotransporter of water in the adult ChP40. Although
established as a key molecular mediator of CSF regulation, ChP
NKCC1 transport direction and its determinants in vivo have
been debated due to the technical challenges of (1) speciﬁcally
manipulating ChP NKCC1 without affecting NKCC1 in other
CSF-contacting cells (ICV application of NKCC1 inhibitors such
as bumetanide suffer from this limitation); and (2) accurately
determining intracellular ion levels of ChP epithelial cells, and
therefore ion gradients, under physiological conditions, as summarized in Supplementary Table 2 and reviewed by Delpire and
Gagnon24. Our in vivo “gain-of-function” approach effectively
bypasses the abovementioned technical limitations. By overexpressing NKCC1 speciﬁcally in the ChP, we could subsequently
observe the resulting CSF K+ and ﬂuid volume changes that
revealed the transporter’s net directionality. Using this approach,
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we found that, in contrast to the common notion that the ChP
constantly produces CSF under physiological conditions, ChPNKCC1 mediates CSF clearance when normal CSF [K+] is above
adult values, especially during the ﬁrst postnatal week in mice.
Future studies should shed light on how this critical period corresponds to the human developmental timeframe, and whether
shared mechanisms during development underlie vulnerability to
disorders involving CSF.
We next demonstrated that ChP clearance of CSF can be targeted to temper abnormal CSF accumulation. CSF adjacent tissues, including ChP, have been targeted for therapeutic
manipulation in rodent models of neurologic diseases ranging
from Huntington’s disease and lysosomal storage disorders, to
Alzheimer’s disease, where transduction of exogenous gene products has improved cardinal features of disease48,57–60. Here,
enhancing ChP epithelial cell NKCC1 transport capacity lessened
the severity of ventriculomegaly in a model of obstructive
hydrocephalus. Our data suggest the possibility of treating congenital hydrocephalus by augmenting endogenous ChP NKCC1
activity to increase CSF absorption rates during early development when CSF [K+] is high. In adult animals, CSF K+ is rapidly
removed when the concentration exceeds homeostatic levels28,29.
It is tempting to speculate that depending on circumstances, ChP
NKCC1 may provide a route for CSF K+ clearance in adults
as well.
10

In light of recent ﬁndings reporting hydrocephalus and ventriculomegaly in children with de novo loss-of-function CHD4
mutations46, we found that the CHD4/NuRD complex is required
for developmental regulation of NKCC1 expression. This connection suggests a possible pathophysiological mechanism
whereby lack of CHD4 activity may reduce NKCC1 levels during
early development (equivalent to P0-P7 in mice), and lead to
insufﬁcient CSF clearance resulting in hydrocephalus. In our
loxP-cre approach, most CHD4 protein knockdown and resulting
attenuation of NKCC1 expression occurred by P14, which is
beyond the critical window of high NKCC1 activity
observed between P0-P7. Improved genetic tools for even earlier
CHD4 knockout and new animal models harboring the de novo
patient mutations would be required to fully unravel the regulatory connection between the CHD4/NuRD complex
and NKCC1.
A key question that emerges from this work is: If ChP NKCC1
mediates net CSF clearance during this transitional developmental stage, what other sources contribute to the inﬂux of early
CSF water and ions? In addition to possible ChP water secretion
that is independent of NKCC1, forebrain progenitor cells that
have a cell body at the ventricular surface and extend their
basal processes to the developing pia could play a role in early
CSF generation61. Consistent with progenitor involvement in
CSF dynamics, recently identiﬁed genes driving pediatric
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hydrocephalus are expressed predominantly by cortical progenitor cells62, and not by the ChP.
In addition to ﬂuid regulation, our newly identiﬁed ChP
clearance route provides a means for regulating extracellular K+
during the ﬁrst postnatal week. Ionic homeostasis of the CSF
plays critical roles in brain development and function. The
enzyme that moves K+ against its individual concentration gradient, the Na+/K+-ATPase (i.e., Atp1a1 and Atp1b1 subunits), is
not yet expressed at adult levels during this period. The ChP
NKCC1-mediated K+ clearance mechanism might assist in
establishing the K+ gradient in a timely manner, which is crucial
for cellular physiology63. Notably, the period of rapidly decreasing CSF [K+] overlaps with the developmental phase when the
excitatory-to-inhibitory “GABA switch” occurs. In early cortical
progenitor cells that reside in the ventricular zone and are bathed
by CSF, the classic inhibitory neurotransmitter GABA leads to
excitatory potentials and suppression of DNA synthesis64. As
newborn cortical neurons differentiate and migrate away from the
ventricular zone, GABA adopts its classic role as an inhibitory
neurotransmitter in the context of lower intracellular Cl− 65,
which is achieved through coordinated activities of neuronal K+/
Cl− co-transporters KCC2 and NKCC166,67. Because ions can
trafﬁc from CSF into interstitial ﬂuid68,69, any interference with
the developmental timeline of ChP NKCC1 function that results
in delayed CSF K+ clearance could potentially increase extracellular/interstitial ﬂuid [K+] and affect global neural excitability63. Speciﬁcally, such a change in extracellular/interstitial
ﬂuid [K+] could fundamentally impact neuronal NKCC1 and
KCC2 transport equilibrium, potentially contributing to a delayed

GABA switch, a phenomenon reported in many models of neurodevelopmental and psychiatric disorders including subtypes of
autism spectrum disorder70, Rett syndrome71, Fragile X syndrome72, schizophrenia73, and Down syndrome74. Furthermore,
extracellular [K+] and certain K+ channels also regulate microglia75, which are critical for synaptic pruning during postnatal
development in mice76. Thus, the ChP is poised to coordinate proper CNS formation by maintaining an optimal extracellular environment at different developmental stages, with
possible effects on neuronal maturation, circuit formation, and
neuroimmune interactions. Similarly, since many experimental
paradigms in neurobiology commonly utilize aCSF to mimic the
extracellular ﬂuid environment, it is important to note that CSF
ionic composition changes substantially over the course
of development. In the present study, we provide ionically
adjusted aCSF recipes with Na+, K+, Ca2+, Mg2+, and Cl− values
for multiple developmental stages including embryonic, neonatal,
postnatal, and adult.
Beyond key ﬁndings and implications during this critical
developmental stage, our study introduced a murine ICP measurement device combined with constant CSF infusion. This
approach can be broadly applied to study the CSF system across
the mouse lifespan. We adapted our tool from clinical practice to
provide a range of options for measuring global cerebral ﬂuid
states that reﬂect the interaction between CSF and cranial tissues.
In later life, CSF homeostasis is maintained by collaborative
efforts from multiple putative players in the brain, including the
ChP, the dural lymphatics14, leptomeningeal vasculature77, and
the ependyma78. While this approach measures overall cranial
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ﬂuid dynamics as one single unit, future applications could apply
mathematical models that have been proposed to isolate the
contribution of distinct CSF outﬂow routes using data acquired
from patients79.
Our ﬁndings reveal that the ChP regulates CSF ﬂuid volume
and ion composition at an early stage, which may play a role in
guiding early brain development. Targeting this absorption route
holds promise for improving ﬂuid management in congenital
hydrocephalus and other brain disorders.

genes (DEGs) that are assigned to a given pathway. The enrichment value is
expressed as a proportion of enriched members to total genes in a deﬁned pathway
and a p-value (Fisher) is calculated for this score; however, false positives have been
reported at up to 10% with this method85. Perturbation, on the other hand, uses
pathway data that applies relationships between gene products rather than only
using a list. Perturbation assigns an impact score based on a mathematical model
that captures the entire topology of the pathway and uses it to calculate how
changes in the expression of each gene in the pathway would perturb the absolute
output of the pathway85. Then, these gene perturbations are combined into a total
perturbation for the entire pathway and a p-value is calculated by comparing the
observed value with what is expected by chance. Motif analyses were performed
using SignalP (v5.086) and TMHMM (v2.087).

Methods
Mice. The Boston Children’s Hospital IACUC approved all experiments involving
mice in this study. Timed pregnant CD1 dams were obtained from Charles River
Laboratories. Mice with germline loxP-CHD4-loxP were imported from MGH and
bred in-house. Both male and female mice were equally included in the study and
were analyzed at postnatal day 0, 7, 14, 21, 28, 5–7 weeks, and 2+ months. Animals
were housed in a temperature and humidity controlled room on a 12-h light/12-h
dark cycle and had free access to food and water. All mice younger than postnatal
day 10 were allocated into gestational/postnatal age groups without respect to sex
(both males and females were included). We intentionally included both males and
females in studies involving mice older than 10 days.
CSF collection and metal detection. CSF was collected by inserting a glass
capillary into cisterna magna, and collected CSF was centrifuged at 10,000 × g for
10 min at 4 °C to remove any tissue debris. Metal quantiﬁcation was performed by
Galbraith Laboratories, Inc (Knoxville, TN, USA). Inductively coupled
plasma–optical emission spectrometry (ICP-OES) was used for K+ and Na+
quantiﬁcation, and ion chromatography (IC) was used for the Cl− quantiﬁcation.
All tests were performed using 5–10 μL of CSF. The quality control (QC) recovered
at 94.4% for K+, 97.7% for Na+, 100.1% for Cl−, 95.1–118% for Mg2+, and 107.5 %
for Ca2+.
TRAP. We used a total of 9 mice aged 8 weeks and 9 litters of mouse embryos aged
E16.5 from the Foxj1:Cre × EGFP-L10a Bacterial Artiﬁcial Chromosome (BAC)
transgenic lines (N = 3 samples of LVChP pooled from 3- to 8-week-old mice or 3
litters of E16.5 embryos). Brain tissue was immediately dissected and used for
TRAP RNA puriﬁcations38. ChP tissues were dissected in ice-cold dissection buffer
(1 × HBSS; 2.5 mM HEPES-KOH; 35 mM glucose; 4 mM NaHCO3; 100 μg/mL
CHX) and homogenized in lysis buffer (20 mM HEPES-KOH; 5 mM MgCl2;
150 mM KCl; 0.5 mM DTT; 1× protease inhibitors; 40 U/mL Rnasin; 20 U/mL
Superasin) at 900 rpm for 12 strokes on ice with Teﬂon pestles in glass tubes
(Kontes). Post-nuclear supernatant was prepared by centrifugation at 4 °C for
10 min at 2000 × g. Post-mitochondrial supernatant was prepared after incubation
with additional 1% NP-40 and 30 mM DHPC, followed by centrifugation at 4 °C
for 10 min at 20,000 × g. Immunoprecipitation was performed with magnetic
streptavidin beads (MyOne T1 Dynabeads; Thermo Fisher #65601) conjugated to
biontinylated anti-GFP antibodies (clones 19C8 and 19F7) for 16 h at 4 °C with
gentle end-over-end rotation. Beads were collected on a magnet on ice, washed four
times with 1000 μL 0.35 M KCl wash buffer (20 mM HEPES-KOH; 5 mM MgCl2;
350 mM KCl; 1% NP-40; 0.5 mM DTT; 100 μg/mL CHX). RNA was eluted in
Stratagene Absolutely RNA Nanoprep Kit (Agilent #400753) lysis buffer (with
β-ME) and puriﬁed according to kit instructions. RNA quality was assessed using
Bioanalyzer Pico Chips (Agilent, 5067-1513) and quantiﬁed using Quant-iT
RiboGreen RNA assay kit (Thermo Fisher Scientiﬁc R11490). Libraries were prepared using Clonetech SMARTer Pico with ribodepletion and Illumina HiSeq to
50NT single end reads. Sequencing was performed at the MIT BioMicroCenter.

Transmission electron microscopy. All tissue processing, sectioning, and imaging
was carried out at the Conventional Electron Microscopy Facility at Harvard
Medical School. Forebrain tissues were ﬁxed in 2.5% glutaraldehyde/2% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). They were then washed
in 0.1 M cacodylate buffer and postﬁxed with 1% osmiumtetroxide (OsO4)/1.5%
potassium ferrocyanide (KFeCN6) for 1 h, washed in water three times and incubated in 1% aqueous uranyl acetate for one hour. This was followed by two washes
in water and subsequent dehydration in grades of alcohol (10 min each; 50%, 70%,
90%, 2 × 10 min 100%). Samples were then incubated in propyleneoxide for 1 h and
inﬁltrated overnight in a 1:1 mixture of propyleneoxide and TAAB Epon (Marivac
Canada Inc. St. Laurent, Canada). The following day, the samples were embedded
in TAAB Epon and polymerized at 60 degrees C for 48 h. Ultrathin sections (about
80 nm) were cut on a Reichert Ultracut-S microtome, and picked up onto copper
grids stained with lead citrate. Sections were examined in a JEOL 1200EX Transmission electron microscope or a TecnaiG² Spirit BioTWIN. Images were recorded
with an AMT 2k CCD camera.
Glycogen and mitochondrial quantiﬁcation. Glycogen and mitochondrial
quantiﬁcation was performed by hand using the ImageJ plugin FIJI88,89. Percentages were calculated by dividing the area of interest by the total area of ChP
epithelial cell within the ﬁeld of view. No other cell types were included in the
analysis. For each condition, analyses were performed across multiple individual
animals (N = 3 for each age). From each animal, 10–20 ﬁelds of view were imaged
at 3000× for glycogen analysis and 5–10 ﬁelds of view were imaged at 3000× for
mitochondrial analysis. Each different ﬁeld of view represented a unique cell or
cells, and ﬁelds of view were chosen such that both the apical and basal surfaces of
the cell were visible. For mitochondrial distribution, a custom MatLab (v.2018)
code was written to extract the centroid from mitochondria data traced in ImageJ
ROIs (Supplementary ﬁle titled “Fig1_Supporting_MitoDistance.m”). Then a distance transformation was performed from each mitochondrion centroid to the
hand-traced apical or basal surfaces. The shortest distance was extracted to calculate the apical: basal proximity ratio, such that 1 = on the apical surface and 0 =
on the basal surface. The analyses included a total of 1747 adult mitochondria,
2241 P7 mitochondria, 2257 P0 mitochondria, and 1123 embryonic mitochondria.
The same groups of embryonic and adult animals were used for the above analysis.

Sequencing data analysis. The raw fastq data of 50-bp single-end sequencing
reads were aligned to the mouse mm10 reference genome using STAR RNA-Seq
aligner (v2.4.0j)80. The mapped reads were processed by htseq-count of HTSeq
software (v 0.6.0)81 with mm10 gene annotation to count the number of reads
mapped to each gene. The Cuffquant module of the Cufﬂinks software (v 2.2.1)82
was used to calculate gene FPKM (Fragments Per Kilobase of transcript per Million
mapped reads) values. Gene differential expression test between different animal
groups was performed using DESeq2 package (v. 1.26.0)83 with the assumption of
negative binomial distribution for RNA-Seq data. Genes with adjusted p-value
< 0.05 are chosen as differentially expressed genes. All analyses were performed
using genes with FPKM > 1, which we considered as the threshold of expression.

Seahorse metabolic analysis. ChP explants were dissected in HBSS (Fisher,
SH30031FS) and maintained on wet ice until plated. Only the posterior leaﬂet of
the P0, P7, and adult ChP was retained for analysis due to empirically determined
limitations of the oxygen availability in the XFe96 Agilent Seahorse system. Tissue
explants were plated on Seahorse XFe96 spheroid microplates (Agilent, 102905100) coated with Cell TAK (Corning), in Seahorse XF Base Medium (Agilent,
102353-100) supplemented with 0.18% glucose, 1 mM L-glutamine, and 1 mM
pyruvate at pH 7.4 and incubated for 1 h at 37 °C in a non-CO2 incubator.
Extracellular acidiﬁcation rates (ECAR) and oxygen consumption rates (OCR)
were measured via the Cell Mito Stress Test (Agilent, 103015-100) with a Seahorse
XFe96Analyzer (Agilent) following the manufacturer’s protocols. Data were processed using Wave software (Agilent). ATP production was calculated as the difference in OCR measurements before and after oligomycin injection, as described
by the manufacturer’s protocol (Agilent, 103015-100). The Cell Mito Stress test was
performed 2–5 independent times (5 for adult; 2 for P7; 2 for P0; 3 for E16.5). The
individual analyses were performed by averaging the readings from both the right
and left hemisphere lateral ventricle ChP for each individual. Data were normalized
by Calcein-AM (2 μM in PBS, Life Technologies L-3224) ﬂuorescence measured at
the end of the assay. Each datum is the normalized average of the 2 LVChP from
each individual normalized to the average of the adult levels run on the same plate
for each assay to account for any experimental variability. Raw and processed ﬁles
are included in source data.

Sequencing pathway and motif analysis. Functional annotation clustering was
performed using DAVID v6.784. Gene ontology (GO) analysis was performed using
AdvaitaBio iPathway guide v.v1702. Enrichment vs. perturbation analysis was
performed by AdvaitaBio iPathway guide v.v1702 and allows comparison of
pathway output perturbation and cumulative geneset expression changes. In brief,
the enrichment analysis is a straightforward geneset enrichment overrepresentation analysis (ORA) considering the number of differentially expressed

High K+ challenge study. Fresh LVChPs were dissected from P4 pups and adult
mice in room temperature HBSS and glued down onto imaging dishes with coverslip bottom. The tissues were incubated at 37 °C with Calcein-AM (Invitrogen L3224; 1:200) for 10 min and then rinsed with 37 °C artiﬁcial CSF (aCSF: 119 mM
NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM glucose, with fresh
1.0 mM magnesium chloride and 2.8 mM calcium chloride; for P4 experiments,
5 mM KCl was used to match with CSF [K+]). Protein was not added to aCSF

12

NATURE COMMUNICATIONS | (2021)12:447 | https://doi.org/10.1038/s41467-020-20666-3 | www.nature.com/naturecommunications

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20666-3

because, while in rat, the protein concentration decreases 10× between P2 and
adult90; this change is only 2× in mouse45 and unlikely to contribute substantially
to the driving force. The tissues were soaked in 1.8 ml aCSF at the beginning of
each imaging session and allowed to stabilize for 10 min. One Z-stack was acquired
to reﬂect the baseline cell volume. Then a 10× KCl solution in aCSF was spiked into
the bath to bring the ﬁnal bath K+ concentration to 50 mM immediately before
imaging continued. A total of ﬁve 3D Z-stacks were acquired throughout a 10-min
imaging session to capture changes in cellular volume over time. Each stack
acquisition took less than 30 s to minimize changes in cell volume from the
beginning to the end of each stack. All imaging studies were carried out at 37 °C.
Image stacks were imported into Imaris (v7.7.1; Bitplane) software. Individual
epithelial cells were identiﬁed by shape. Cells with discrete borders that were
present at all timepoints and had dark pixels both above and below them in Z for
the whole timecourse were selected a priori and then traced by hand using the
“Surpass” functionality to create a 3D surface volume through all Z-stacks based on
Calcein-AM uptake signal. Due to known z-step distance and interpolation
between the planes, Imaris calculated the number of voxels for each cell. This
analysis was then repeated for the same cell throughout the timecourse. We veriﬁed
manually that the same cell was analyzed throughout the timecourse based on the
topology of the surrounding cells, allowing for adjustment for any x–y drifting that
occurred. The relative volume was calculated as dV/V0 for each timepoint (t) where
V0 is the initial volume of the cell, t is each subsequent timepoint after addition of
challenge, and dV = Vt − V0. In LVChP from each animal, 5 distinct cells were
analyzed and their values at each timepoint were averaged to represent the average
value for each animal. A total of 4 animals (N = 4) were analyzed from each
age group.
Tissue processing. Samples were ﬁxed in 4% paraformaldehyde (PFA). For
cryosectioning, samples were incubated in the following series of solutions: 10%
sucrose, 20% sucrose, 30% sucrose, 1:1 mixture of 30% sucrose and OCT (overnight), and OCT (1 h). Samples were frozen in OCT.
Immunostaining. Cryosections were blocked and permeabilized (0.3% Triton X100 in PBS; 5% serum), incubated in primary antibodies overnight and secondary
antibodies for 2 h. Sections were counterstained with Hoechst 33342 (Invitrogen
H3570, 1:10,000) and mounted using Fluoromount-G (SouthernBiotech). The
following primary antibodies were used: chicken anti-GFP (Abcam ab13970;
1:1000), mouse anti-Aqp1 (Santa Cruz sc-32737; 1:100), rabbit anti-CHD4 (Abcam
ab72418, 1:200), rabbit anti-NKCC1 (Abcam ab59791; 1:500), rat anti-HA (Roche
11867423001; 1:1000). Secondary antibodies were selected from the Alexa series
(Invitrogen, 1:500). Images were acquired using Zeiss LSM880 confocal microscope
with ×20 objective and ×63 oil objective. ZEN Black software was used for image
acquisition and ZEN Blue used for Airy processing.
Co-IP. Tissues were homogenized in NET buffer (150 mM NaCl, 10 mM Tris 8.0,
5 mM EDTA, 10% glycerol and 2% Triton X-100) supplemented with protease
inhibitors. Protein concentration was determined by BCA assay (Thermo Scientiﬁc
23227). Lysates with same amount of total protein (250–1000 μg based on
experiments) were precleared at 4 °C for 2 hr with Protein G agarose and then
incubated with desired antibody or control antibody at 4 °C overnight (no beads
present during antibody incubation). Protein G agarose beads were added to lysateantibody mixture after overnight incubation for 2 h. Beads were washed thoroughly
and then eluted by boiling in 2% SDS. ChP tissues were pooled across seven litters
of P0 pups and 30 adults to achieve sufﬁcient protein for Co-IP.
Immunoblotting. Tissues were homogenized in RIPA buffer supplemented with
protease and phosphatase inhibitors. Protein concentration was determined by
BCA assay (Thermo Scientiﬁc 23227). Samples were denatured in 2% SDS with 2mercaptoethanol by heating at 37 °C (for NKCC1) or 95 °C (for CHD4 and other
NuRD complex proteins) for 5 min. Equal amounts of proteins were loaded and
separated by electrophoresis in a 4–15% gradient polyacrylamide gel (BioRad
#1653320) or NuPAGE 4–12% Bis-Tris gel (Invitrogen #NP0322), transferred to a
nitrocellulose membrane (250 mA, 1.5 h, on ice), blocked in ﬁltered 5% BSA or
milk in TBST, incubated with primary antibodies overnight at 4 °C followed by
HRP conjugated secondary antibodies (1:5000) for 1 h, and visualized with ECL
substrate. For phosphorylated protein analysis, the phosphoproteins were probed
ﬁrst, and then blots were stripped (Thermo Scientiﬁc 21059) and reprobed for total
proteins. For co-IP protein analysis, TrueBlot secondary antibody (eBioscience 188816-33) was used to detect only nondenatured IgG and avoid background signal
from IP antibody. The following primary antibodies were used: rabbit anti-NKCC1
(Abcam ab59791; 1:1000), rabbit anti-pNKCC1 (EMD Millipore ABS1004; 1:1000),
rabbit anti-ATP1a1 (Upstate C464.6/05-369; 1:250), goat anti-Klotho (R&D
AF1819-sp; 1:200), rabbit anti-GAPDH (Sigma G9545; 1:10,000), mouse anti-HA
(Abcam ab130275; 1:1000), rabbit anti-CHD4 (Abcam ab72418; 1:2000), rabbit
anti-MBD3 (Abcam ab157464; 1:1000), rabbit anti-HDAC1 (Abcam ab7028;
1:2000), mouse anti-HDAC2 (Abcam 51832; 1:2000). The same protein samples
were blotted for multiple targets to allow controlled quantitative comparison
(i.e., NKCC1 and GAPDH). Raw blot images are included in Source Data.
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Quantitative RT-PCR. For mRNA expression analyses, the ChP were dissected
and pooled from 2 pups. RNA was isolated using the MirVana miRNA isolation kit
(Invitrogen AM1561) following manufacturer’s speciﬁcations without miRNA
enrichment step. Extracted RNA was quantiﬁed spectrophotometrically and 100 ng
was reverse-transcribed into cDNA using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems #4368814) following manufacturer’s speciﬁcations. RT-qPCRs were performed in duplicate using Taqman Gene Expression
Assays and Taqman Gene Expression Master Mix (Applied Biosystems) with
GAPDH as an internal control. Cycling was executed using the StepOnePlus RealTime PCR System (Invitrogen) and analysis of relative gene expression was performed using the 2−ΔΔCT method. Technical replicates were averaged for their
cycling thresholds and further calculations were performed with those means. Each
RNA sample was analyzed for multiple genes.
In utero intracerebroventricular injection (ICV). Timed pregnant mice (E14.5)
were anesthetized with isoﬂurane and warmed. Laparotomy was performed.
Embryos were stabilized by hand and lateral ventricles were visually identiﬁed.
AAV solution was delivered into lateral ventricles using ﬁne glass capillary pipettes
with beveled tips. The AAV solution contained (0.01%) Fast Green FCF (Sigma
F7252-5G) to aid with visualization. Uterine horns were returned into the
abdominal space, and the incision was sutured. Meloxicam analgesia was longitudinally delivered according to IACUC protocol.
Intraventricular kaolin injection in postnatal pups. Postnatal day 4 pups (P4)
were anesthetized. A small incision was made in the scalp, and 1 μl of sterile kaolin
solution (25% in PBS) was injected into the left lateral ventricle using glass capillary
pipettes. The injection site with corresponding lateral ventricle localization was
determined as between bregma and lambda, and 1 mm from mid-line. The skin
incision was sutured and reinforced with Vetbond (3MTM ID 70200742529). The
pups were warmed and returned to the dam.
AAV production. The original AAV-NKCC1 plasmid was purchased from
Addgene (pcDNA3.1 HA CFP hNKCC1 WT (NT15-H) was a gift from Biff Forbush: Addgene plasmid # 49077; http://n2t.net/addgene:49077; RRID:
Addgene_49077). The plasmid carries an 3×HA tag at the N-terminal of NKCC1 to
allow detection and separation from endogenous NKCC1. The CFP tag was
removed by BsaI digestion to reduce insert size for AAV production. Virus production and puriﬁcation were performed by the Penn Vector Core. The very large
size of the plasmid resulted in variable transduction efﬁciency. All mice receiving
AAV-NKCC1 were analyzed for HA expression after every experiment to conﬁrm
transduction efﬁciency. AAV-GFP and AAV-Cre were purchased from the Boston
Children’s Hospital Viral Core.
Magnetic resonance imaging (MRI). Mice were imaged using Bruker BioSpec
small animal MRI (7T) at 2 week and P50 while under anesthesia by isoﬂurane. A
warm pad was used to maintain body temperature. Breathing rate and heart rate
were monitored to reﬂect the depth of anesthesia. All axial T2 images were
acquired using the following criteria: TE/TR = 60/4000; Ave = 8; RARE = 4; slice
thickness = 0.6 mm. Ventricle volumes were calculated by manual segmentation
using FIJI/ImageJ. Brain sizes were calculated by averaging total cross-sectional
areas from the four highlighted slices (red) with visible LV and 3 V in control mice
(corresponding slices were used in AAV-NKCC1 regardless of visibility of ventricles). Ventricle regions were not excluded from the brain size measurements. In
studies with unilateral kaolin injection, 3D reconstruction of the ventricles was
performed by manual segmentation in ITK-SNAP91 and exported through
ParaView.
Constant rate CSF infusion test (ICP and compliance measurement). An
apparatus was developed to perform a constant infusion test in mice through a
single catheter for both infusion of CSF and monitoring of ICP. A 20-cc syringe
was ﬁlled with aCSF and placed in an automated infusion pump (GenieTouch,
Kent Scientiﬁc Co., Denver) set to deliver a constant rate infusion of 1–4 uL/min.
The syringe was connected via pressure tubing to hemostasis valve Y connector
(Qosina, NY). A ﬁberoptic ICP sensor (Fiso Technologies Inc, Quebec, Canada)
was inserted through the other port of the rotating hemostat and then into
0.55 mm diameter catheter until the sensor was ﬂush with the catheter’s distal tip.
The entire apparatus and tubing was carefully screened to ensure the absence of air
bubbles. Adult mice were then deeply anesthetized, placed on a warm pad, and
head-ﬁxed with ear bars. The distal end of the infusion device (catheter with
ﬁberoptic sensor) was placed inside the lateral ventricle through a hole made by a
hand-held twist drill with a #74 wire gauge bit (−0.4 mm (anterior-posterior) and
1.2 mm (medial-lateral) with respect to Bregma, and a depth of 2 mm from the
outer edge of the skull); the catheter was then sealed with Vetbond (3 M, Minnesota). Intraventricular access and water-tight seal was conﬁrmed by observation
of arterial and respiratory waveforms in the ICP signal and a transient rise in ICP
upon gentle compression of the abdomen and thorax. Two min of baseline ICP
were recorded before initiating the infusion of aCSF. As the infusion proceeded,
careful observation was made of the mouse’s respiratory rate. After the ICP level
reached a new plateau, the infusion was discontinued. Parameters of the Marmarou
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model of CSF dynamics for constant rate infusions were estimated by a non-linear
least squares ﬁt of the model to the ICP data54
h
i
p0
iinfusion þ ICPbaseline
 ½ICPbaseline  p0 
RCSF
i 3
ICP ðt Þ ¼
2 h
ICPbaseline p0
iinfusion þ

ð1Þ
RCSF
6
t7
ICPbaseline p0
Ci
þ iinfusion  4e
5
RCSF
where iinfusion is the rate of infusion, ICPbaseline is the ICP level before infusion, p0 is
a pressure in the storage arm of the model, RCSF is the resistance to CSF outﬂow,
and Ci is the compliance coefﬁcient.
Statistics and reproducibility. Biological replicates (N) were deﬁned as samples
from distinct and biologically independent individual animals, analyzed either in
the same experiment or within multiple experiments, with the exception when
individual animal could not provide sufﬁcient sample (i.e., CSF), in which case
multiple animals were pooled into one distinct biological replicate and most details
are stated in the corresponding ﬁgure legends. Due to limited space, these metrics
for Fig. 1 are listed here: Fig. 1a–b contain data from three independent experiments for N = 6 biological replicates. Figure 1c Data from two independent
experiments with a total of three biologically independent samples. d–f. N = 3
distinct animals from two independent experiments (same images analyzed in d, e,
and f), 5–10 ﬁeld of view (FOV) per animal (See source data for exact numbers of
FOV), distinct cells were captured in each FOV. Figure 1h, i N = 26 E16.5 embryos
(4 litters); N = 19 P0 pups (2 litters); N = 12 P7 pups (2 litters); N = 16 adults. Data
are from ﬁve independent experiments for adult; two independent experiments for
P7 and P0; three independent experiments for E16.5. Each datapoint is an average
of the 2 LVChP from an individual. j–k N = 3 animals per age; 433–833 mitochondria per individual.
The following measurements were taken using the same set of samples/animals:
mitochondria/glycogen quantiﬁcation, immunoblotting, qPCR, and different
parameters from CSF infusion tests (ICP, compliance, RCSF). In these cases the
same image, protein or RNA samples, and mice were analyzed for multiple
readouts and targets, to allow controlled quantitative comparison. Statistical
analyses were performed using Prism 7 or R. Outliers were excluded using ROUT
method (Q = 1%). Appropriate statistical tests were selected based on the
distribution of data, homogeneity of variances, and sample size. The majority of the
analyses were done using one-way ANOVA with multiple comparison correction
(Sidak) or Welch’s two-tailed unpaired t-test, except for Fig. 1d–f, and Fig. 1h, i
where the analysis was done by Welch’s ANOVA with Dunnett’s T3 multiple
comparison test, and Fig. 1k–l where the analysis was done using
Kolmogorov–Smirnov test. F tests or Bartlett’s tests were used to assess
homogeneity of variances between data sets. Parametric tests (t-test, ANOVA) were
used only if data were normally distributed and variances were approximately
equal. Otherwise, nonparametric alternatives were chosen. Data are presented as
mean ± standard deviation (SD). If multiple measurements were taken from a
single individual, data are presented as mean ± standard errors of the mean
(SEMs). Please refer to ﬁgure legends for sample size and technical replicate
numbers. p values < 0.05 were considered signiﬁcant (*p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001). Exact p values can be found in the ﬁgure legends.
P values are also marked in the ﬁgures where space allows.
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
Sequencing data from TRAP study (for Fig. 2 and Supplementary Fig. 4) are available in
GEO (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138970; accession
number 138970). All other data are available from the authors. All biological material
were either directly commercially available or are available upon request from the
lab. Source data are provided with this paper.
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Code availability
The custom MatLab code is provided as supplementary for Fig. 1 and Supplementary
Fig. 3 (Fig1_Supporting_MitoDistance.m). The code is also available on GitHub
(https://github.com/LehtinenLab/Xu-Fame-2020). All other data are available in the
main text or the supplementary materials.
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